Alternatives to Mycophenolic Acid If You Can't Fill Your Prescription

Mycophenolic acid—available as Myfortic (mycophenolate sodium) and in the closely related prodrug form CellCept (mycophenolate mofetil)—is a critical immunosuppressant for millions of transplant recipients. But what happens if your pharmacy can't fill it? Are there alternatives?

The answer is: potentially yes—but only under the direct guidance of your transplant physician. Never attempt to switch or stop your immunosuppressant regimen on your own. This guide explains what alternatives your doctor might consider and what the process looks like.

Critical Warning: Never Stop or Switch Immunosuppressants Without Your Doctor

Before discussing alternatives, this point cannot be overstated: stopping or modifying your immunosuppressant regimen without physician guidance can lead to acute organ rejection—which may be irreversible and life-threatening. If your pharmacy is out of mycophenolic acid, call your transplant team immediately. Do not skip doses waiting for the medication to be restocked.

Can You Switch Between Myfortic and CellCept?

The first alternative your transplant team may consider is switching between formulations. Myfortic (mycophenolate sodium, the enteric-coated form) and CellCept (mycophenolate mofetil, the prodrug form) are not identical, but both deliver mycophenolic acid to the body. However, their absorption rates differ, so they cannot simply be swapped milligram-for-milligram.

The standard equivalence is: 720 mg Myfortic ≈ 1,000 mg CellCept on a mole-to-mole basis. This is a conversation you need to have with your doctor—do not attempt this switch on your own.

Alternative 1: Azathioprine (Imuran, Azasan)

Azathioprine is the oldest antimetabolite immunosuppressant and was the standard of care in transplantation before mycophenolate became available in 1995. It works by interfering with purine synthesis and DNA replication in lymphocytes.

Pros: Long track record in transplantation, widely available, generally less expensive, generic available

Cons: Studies show mycophenolate mofetil is more effective than azathioprine at preventing acute rejection in the first 6 months post-transplant; requires TPMT enzyme testing before use

Important note: Because both azathioprine and mycophenolate inhibit purine metabolism, they should NOT be used together. They must be switched, not added.

Alternative 2: Sirolimus (Rapamune)

Sirolimus (brand name Rapamune) is an mTOR inhibitor that suppresses the immune system through a different mechanism than mycophenolate. It inhibits T-cell activation and proliferation by blocking the mammalian target of rapamycin (mTOR) pathway.

Pros: Different mechanism, useful if gastrointestinal side effects from mycophenolate were problematic; also has antitumor and antiviral properties

Cons: Can impair wound healing, cause hyperlipidemia, mouth sores, and pneumonitis; requires therapeutic drug monitoring; generally not used immediately post-transplant due to wound healing concerns

Alternative 3: Everolimus (Zortress)

Everolimus is another mTOR inhibitor, similar in mechanism to sirolimus, approved for use in kidney transplant patients to prevent organ rejection. It may be used in combination with reduced-dose tacrolimus as an alternative to mycophenolate-based regimens in selected patients.

Pros: FDA-approved for kidney transplant; antiproliferative and antiviral properties; may reduce calcineurin inhibitor exposure and protect kidney function

Cons: Similar side effects to sirolimus; requires careful therapeutic drug monitoring; not appropriate for all patients

Alternative 4: Belatacept (Nulojix)

Belatacept is a costimulation blocker approved for kidney transplant rejection prevention. It works by blocking the activation of T cells at a different point in the immune response compared to calcineurin inhibitors or antimetabolites.

Pros: Preserves kidney function better than calcineurin inhibitor-based regimens in some patients; monthly IV infusion instead of daily pills

Cons: Higher risk of post-transplant lymphoproliferative disorder (PTLD), especially in EBV-negative patients; IV administration required; not a simple swap from oral mycophenolate

What About Off-Label Autoimmune Uses?

If you take mycophenolate mofetil off-label for an autoimmune condition (such as lupus nephritis, vasculitis, or pemphigus vulgaris), your physician may have more flexibility in the short term. Alternatives in this setting could include azathioprine, methotrexate, or cyclophosphamide depending on the condition—but again, this decision must be made with your rheumatologist or treating physician.

The Bottom Line: Always Call Your Doctor First

No alternative to mycophenolic acid should be initiated without physician supervision. If you're struggling to find your medication, contact your transplant team immediately, and use resources like medfinder to locate your medication in stock at nearby pharmacies before assuming a switch is necessary.

For more on why this medication can be hard to find, read our guide: Why Is Mycophenolic Acid So Hard to Find?.